Lv5
1176 积分 2024-08-19 加入
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial
1个月前
已完结
Intratumoural vaccination via checkpoint degradation-coupled antigen presentation
6个月前
已完结
Modelling the Cost Effectiveness of Lamivudine/Zidovudine Combination Therapy in HIV Infection
6个月前
已完结
WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors
7个月前
已完结
BOP2-Comb: Bayesian Optimal Phase II Design for Optimizing Doses and Assessing Contribution of Components in Drug Combinations
8个月前
已完结
Bayesian optimal phase II designs with dual‐criterion decision making
8个月前
已完结
BOP2-FE: Bayesian optimal phase II design with futility and efficacy-stopping boundaries
8个月前
已完结
Digital twins for the personal touch
9个月前
已完结
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
10个月前
已完结
BOP2-TE: Bayesian optimal phase 2 design for jointly monitoring efficacy and toxicity with application to dose optimization
11个月前
已完结
皖公网安备34019202002308
